文档介绍：Infect Dis Clin N Am
20 (2006) xiii–xv
Preface
Bioterrorism and Bioterrorism Preparedness
Nancy Khardori, MD, PhD
Guest Editor
On September 9, 2001, the world witnessed the most graphic and das-
tardly display of how modern technology can be put to evil use. This was
followed by the intentional use of microbiology technology to harm hu-
mans. We proudly watched as a practicing colleague, Larry Bush, of Flor-
ida, made a diagnosis of anthrax from an mon presentation of the
disease.
Around this time, our team was in the process of convening an educa-
tional program on behalf of the Association of Practitioners in Infection
Control. West Nile virus was new in our area, and the number of patients
with hepatitis C being sent to us was increasing rapidly. These were the
topics originally included in our program planned for November 15, 2001.
While working on the brochure, I looked up the Centers for Disease Control
and Prevention’s Categories of Bioterrorism Agents. As I scanned the list of
category A agents with the highest potential for causing mass casualties, I
realized that at one point or another in my professional career as an infec-
tious diseases clinician and a microbiologist spanning across two different
continents, I had seen or diagnosed them all. I had seen cutaneous anthrax
and woolsorter’s disease as a medical student in the sheep raising and wool
carding area of Kashmir, India; smallpox as a young village physician in the
early 1970s; Kyasanur Forest disease, a viral hemorrhagic fever, during my
post–medical school doctoral training in microbiology; botulism during the
outbreak in Peoria, Illinois, from home-canned mushrooms, while I was an
ICU resident at Southern Illinois University School of Medicine in Spring-
field, Illinois; plague during the last outbreak in Gujarat, India, in 1994; and
0891-5520/06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved.
doi:. id.
xiv PREFACE
tular